PRECLINICAL INVESTIGATION OF 3-DEAZANEPLANOCIN A (DZNEP) ANALOG 1-3 AS A NEW EPIGENETIC ANTICANCER AGENT IN HUMAN ACUTE MYELOID LEUKEMIA (AML) AND METASTATIC BREAST CANCER
Ph.D
Saved in:
Main Author: | JIANG XIA |
---|---|
Other Authors: | PHYSIOLOGY |
Format: | Theses and Dissertations |
Language: | English |
Published: |
2014
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/53782 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
COMBINATORIAL MOLECULAR PHARMACOLOGICAL AND PRECLINICAL STUDIES OF AN EPIGENETIC ANTICANCER DRUG, 3-DEAZANEPLANOCIN A, IN RATS
by: SUN FENG
Published: (2011) -
Functional characterization of D9, a novel deazaneplanocin a (DZNep) analog, in targeting acute myeloid leukemia (AML)
by: Jiang, Xia, et al.
Published: (2015) -
TARGETING THE EPIGENETIC MECHANISM IN ACUTE MYELOID LEUKAEMIA
by: ZHOU YAFENG
Published: (2016) -
Improved outcome in childhood acute myeloid leukemia in Singapore with the MRC AML 10 protocol
by: Tan, R.M., et al.
Published: (2011) -
RUNX1 meets MLL: Epigenetic regulation of hematopoiesis by two leukemia genes
by: Koh, C.P., et al.
Published: (2014)